Reaching the Macrophage: Routes of Delivery

  • G. Kraal
  • N. van Rooijen
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 158)

Abstract

The functional heterogeneity of macrophages based on anatomical localization and receptor expression as well as their versatile way through which they react to different stimuli makes them key players in many processes of the body. To stimulate or downregulate their functions in therapeutic ways using their extremely efficient phagocytosis capacity, one has to consider that they are often located at sites that are hard to reach. Local administration of drugs is therefore often the method of choice whereby liposomes seem to be an ideal vehicle through their versatility and relative ease of handling, as well as their efficient uptake by macrophages. Especially the use of the macrophage suicide technique has enabled the study of many functions of the macrophage. An overview is given of the many routes that can be used to reach the macrophage at different sites and the effects this has on the function of the cell.

Keywords

Liposomes Phagocytosis Clodronate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593–623PubMedCrossRefGoogle Scholar
  2. Barbe E, Huitinga I, Dopp EA, Bauer J, Dijkstra CD (1996) A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding. J Cell Sci 109:2937–2945PubMedGoogle Scholar
  3. Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N, de Waal Malefijt MC, et al (2000) Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum 43:1951–1959PubMedCrossRefGoogle Scholar
  4. Bergh A, Damber JE, van Rooijen N (1993) The human chorionic gonadotrophin-induced inflammation-like response is enhanced in macrophage-depleted rat testes. J Endocrinol 136:415–420PubMedCrossRefGoogle Scholar
  5. Biewenga J, van der Ende MB, Krist LF, Borst A, Ghufron M, van Rooijen N (1995) Macrophage depletion in the rat after intraperitoneal administration of liposome-encap-sulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund’s adjuvant. Cell Tissue Res 280:189–196PubMedGoogle Scholar
  6. Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545–568PubMedCrossRefGoogle Scholar
  7. Delemarre FG, Kors N, Kraal G, van Rooijen N (1990) Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J Leukoc Biol 47:251–257PubMedGoogle Scholar
  8. Fadok VA, Bratton DL, Henson PM (2001) Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. Journal of Clinical Investigation 108:957–962PubMedGoogle Scholar
  9. Fathi M, Johansson A, Lundborg M, Orre L, Skold CM, Camner P (2001) Functional and morphological differences between human alveolar and interstitial macrophages. Experimental and Molecular Pathology 70:77–82PubMedCrossRefGoogle Scholar
  10. Gerber JS, Mosser DM (2001) Stimulatory and inhibitory signals originating from the macrophage Fc gamma receptors. Microbes and Infection 3:131–139PubMedCrossRefGoogle Scholar
  11. Gregoriadis G (1995) Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 13:527–537PubMedCrossRefGoogle Scholar
  12. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T (1993) Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 177:397–407PubMedCrossRefGoogle Scholar
  13. Janeway CA Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13:11–16PubMedCrossRefGoogle Scholar
  14. Kraal G (1992) Cells in the marginal zone of the spleen. Int Rev Cytol 132:31–74PubMedCrossRefGoogle Scholar
  15. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601–637PubMedCrossRefGoogle Scholar
  16. Laskin DL, Weinberger B, Laskin JD (2001) Functional heterogeneity in liver and lung macrophages. Journal of Leukocyte Biology 70:163–170PubMedGoogle Scholar
  17. Litzinger DC, Buiting AM, van Rooijen N, Huang L (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1190:99–107PubMedCrossRefGoogle Scholar
  18. Medzhitov R, Janeway C Jr (2000) The Toll receptor family and microbial recognition. Trends Microbiol 8:452–456PubMedCrossRefGoogle Scholar
  19. Nolte M (2002) Compartments, cells and molecules in the spleen, Academic thesis. Vrije Universiteit medical center, AmsterdamGoogle Scholar
  20. Pantelidis P, McGrath DS, Southcott AM, Black CM, du Bois RM (2001) Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific. Respiratory Research 2:365–372PubMedCrossRefGoogle Scholar
  21. Pearson AM (1996) Scavenger receptors in innate immunity. Curr Opin Immunol 8:20–28PubMedCrossRefGoogle Scholar
  22. Peiser L, Mukhopadhyay S, Gordon S (2002) Scavenger receptors in innate immunity. Curr Opin Immunol 14:123–128PubMedCrossRefGoogle Scholar
  23. Platt N, Gordon S (2001) Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse’s tale. Journal of Clinical Investigation 108:649–654PubMedGoogle Scholar
  24. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S (1996) Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proceedings of the National Academy of Sciences of the United States of America 93:12456–12460Google Scholar
  25. Polfliet MM, Goede PH, van Kesteren-Hendrikx EM, van Rooijen N, Dijkstra CD, van den Berg TK (2001) A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. J Neuroimmunol 116:188–195PubMedCrossRefGoogle Scholar
  26. Rabinovitch M (1995) Professional and Nonprofessional Phagocytes - an Introduction. Trends in Cell Biology 5:85–87PubMedCrossRefGoogle Scholar
  27. Ravetch JV (1997) Fc receptors. Curr Opin Immunol 9:121–125PubMedCrossRefGoogle Scholar
  28. Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421–432PubMedCrossRefGoogle Scholar
  29. Riches DWH (1995) Signaling Heterogeneity as a Contributing Factor in Macrophage Functional Diversity. Seminars in Cell Biology 6:377–384PubMedCrossRefGoogle Scholar
  30. Savill J (1998) Apoptosis - Phagocytic docking without shocking. Nature 392:442–443PubMedCrossRefGoogle Scholar
  31. Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte Recognition of Cells Undergoing Apoptosis. Immunology Today 14:131–136PubMedCrossRefGoogle Scholar
  32. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G (2000) Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 157:1671–1683PubMedCrossRefGoogle Scholar
  33. Stahl PD, Ezekowitz RA (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50–55PubMedCrossRefGoogle Scholar
  34. Stein M, Gordon S (1991) Regulation of Tumor-Necrosis-Factor (Tnf) Release by Murine Peritoneal-Macrophages - Role of Cell Stimulation and Specific Phagocytic Plasma-Membrane Receptors. European Journal of Immunology 21:431–437PubMedCrossRefGoogle Scholar
  35. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76:519–529PubMedCrossRefGoogle Scholar
  36. Thepen T, Van Rooijen N, Kraal G (1989) Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 170:499–509PubMedCrossRefGoogle Scholar
  37. Thepen T, van Vuuren AJ, Kiekens RC, Damen CA, Vooijs WC, van De Winkel JG (2000) Resolution of cutaneous inflammation after local elimination of macrophages. Nat Biotechnol 18:48–51PubMedCrossRefGoogle Scholar
  38. van Rooijen N, Bakker J, Sanders A (1997) Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol 15:178–185PubMedCrossRefGoogle Scholar
  39. van Rooijen N, Claassen E, Kraal G, Dijkstra CD (1989a) Cytological basis of immune functions of the spleen. Immunocytochemical characterization of lymphoid and non-lymphoid cells involved in the ’in situ’ immune response. Prog Histochem Cyto-chem 19:1–71Google Scholar
  40. van Rooijen N, Kors N, Kraal G (1989b) Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J Leukoc Biol 45:97–104PubMedGoogle Scholar
  41. Van Rooijen N, Kors N, vd Ende M, Dijkstra CD (1990) Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 260:215–222PubMedCrossRefGoogle Scholar
  42. Van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174:83–93PubMedCrossRefGoogle Scholar
  43. van Rooijen N, Sanders A (1997) Elimination, blocking, and activation of macrophages: three of a kind? J Leukoc Biol 62:702–709PubMedGoogle Scholar
  44. van Rooijen N, ter Hart H, Kraal G, Kors N, Claassen E (1992) Monoclonal antibody mediated targeting of enzymes. A comparative study using the mouse spleen as a model system. J Immunol Methods 151:149–155PubMedCrossRefGoogle Scholar
  45. Wright SD, Silverstein SC (1983) Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 158:2016–2023PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • G. Kraal
    • 1
  • N. van Rooijen
    • 1
  1. 1.Department of Molecular Cell BiologyVrije Universiteit Medical CenterAmsterdamThe Netherlands

Personalised recommendations